Pseudomonas aeruginosa is one of the most important opportunistic human pathogens worldwide. High prevalence of Multi Drug Resistant P. aeruginosa (MDRPa) in Iran is a serious problem for antimicrobial therapy. Several studies have reported the MDRPa in Europe and Asia. Due to the use of broad-spectrum antibiotics, bacterial resistance is increasing in Iran, located in Middle East. The present cross-sectional study was designed to investigate the prevalence of class1 integron, resistance gene cassettes and antimicrobial susceptibility profiles among isolates of P. aeruginosa in Al-Zahra Hospital, Isfahan City, central part of Iran from Jan-Sep 2014. The aim of this study was to determine the antimicrobial susceptibility, the prevalence of Class1 integron, resistance gene a measuring in Iran. A total of 231 P. aeruginosa isolates were collected from clinical specimens including urine (50.6%), tracheal tube (25.5%), wound (13.4%), blood (6.1%), catheter (2.2%), cerebrospinal fluid (1.7%) and sputum (0.4%) isolates from hospitalized patients (mean age: 50.27 ± 24.12 years).The majority of patients (68%) were male. Isolates were collected from different parts of the hospital as follows: ICU, Internal Medicine, Emergency care, Pediatrics, Nephrology, Transplant Center, General surgery and Infectious. Revealed data show a high rate of MDR P. aeruginosa isolates in the studied area; also, the result signifies the spread of aadA6 among clinical isolates in hospitalized patients.
References
[1]
Fazeli, H., Sadighian, H., Esfahani, B.N. and Pourmand, M.R. (2013) Identification of Class-1 Integron and Various Β-Lactamase Classes among Clinical Isolates of Pseudomonas aeruginosa at Children’s Medical Center Hospital. Journal of Medical Bacteriology, 1, 25-36.
[2]
Strateva, T. and Yordanov, D. (2009) Pseudomonas Aeruginosa—A Phenomenon of Bacterial Resistance. Journal of Medical Microbiology, 589, 1133-1148. http://dx.doi.org/10.1099/jmm.0.009142-0
[3]
Kobayashi, K., Hayashi, I., Kouda, S., Kato, F., Fujiwara, T., Kayama, S., et al. (2013) Identification and Characterization of a Novel Aac (6′)-Iag Associated with the blaIMP-1-Integron in a Multidrug-Resistant Pseudomonas aeruginosa. PloS ONE, 8, e70557.
[4]
Xu, Z., Li, L., Shirtliff, M.E., Alam, M., Yamasaki, S. and Shi, L. (2009) Occurrence and Characteristics of Class 1 and 2 Integrons in Pseudomonas aeruginosa Isolates from Patients in Southern China. Journal of Clinical Microbiology, 47, 230-234. http://dx.doi.org/10.1128/JCM.02027-08
[5]
Moazami-Goudarzi, S. and Eftekhar, F. (2013) Assessment of Carbapenem Susceptibility and Multidrug-Resistance in Pseudomonas aeruginosa Burn Isolates in Tehran. Jundishapur Journal of Microbiology, 6, 162-165.
[6]
Fonseca, é.L., Vieira, V.V., Cipriano, R. and Vicente, A.C. (2005) Class 1 Integrons in Pseudomonas aeruginosa Isolates from Clinical Settings in Amazon Region, Brazil. FEMS Immunology and Medical Microbiology, 44, 303-309. http://dx.doi.org/10.1016/j.femsim.2005.01.004
[7]
Kiddee, A., Henghiranyawong, K., Yimsabai, J., Tiloklurs, M. and Niumsup, P.R. (2013) Nosocomial Spread of Class 1 Integron-Carrying Extensively Drug-Resistant Pseudomonas aeruginosa Isolates in a Thai Hospital. International Journal of Antimicrobial Agents, 42, 301-306.
[8]
Hall, G.S. (2007) Nonfermenting and Miscellaneous Gram Negative Bacilli. In: Mahon, C.R., Lehman, D.C. and Manuselis, G., Eds., Textbook of Diagnostic Microbiology, 3rd Edition, Saunders-Elsevier, Ohio, 564-584.
[9]
Odumosu, B.T., Adeniyi, B.A. and Chandra, R. (2013) Analysis of Integrons and Associated Gene Cassettes in Clinical Isolates of Multidrug Resistant Pseudomonas aeruginosa from Southwest Nigeria. Annals of Clinical Microbiology and Antimicrobials, 12, 21-29. http://dx.doi.org/10.1186/1476-0711-12-29
[10]
Nikokar, I., Tishayar, A., Flakiyan, Z., Alijani, K., Rehana-Banisaeed, S., Hossinpour, M., et al. (2013) Antibiotic Resistance and Frequency of Class 1 Integrons among Pseudomonas aeruginosa, Isolated from Burn Patients in Guilan, Iran. Iranian Journal of Microbiology, 5, 36-41.
[11]
Gillings, M., Boucher, Y., Labbate, M., Holmes, A., Krishnan, S., Holley, M., et al. (2008) The Evolution of Class 1 Integrons and the Rise of Antibiotic Resistance. Journal of Bacteriology, 190, 5095-5100. http://dx.doi.org/10.1128/JB.00152-08
[12]
Chen, J., Su, Z., Liu, Y., Wang, S., Dai, X., Li, Y., et al. (2009) Identification and Characterization of Class 1 Integrons among Pseudomonas aeruginosa Isolates from Patients in Zhenjiang, China. International Journal of Infectious Diseases, 13, 717-721. http://dx.doi.org/10.1016/j.ijid.2008.11.014
[13]
Shahcheraghi, F., Badmasti, F. and Feizabadi, M.M. (2010) Molecular Characterization of Class 1 Integrons in MDR Pseudomonas aeruginosa Isolated from Clinical Settings in Iran, Tehran. FFEMS Immunology and Medical Microbiology, 58, 421-425. http://dx.doi.org/10.1111/j.1574-695X.2009.00636.x
[14]
Severino, P. and Magalhães, V.D. (2002) The Role of Integrons in the Dissemination of Antibiotic Resistance among Clinical Isolates of Pseudomonas aeruginosa from an Intensive Care Unit in Brazil. Research in Microbiology, 153, 221-226. http://dx.doi.org/10.1016/S0923-2508(02)01310-4
[15]
Recchia, G.D. and Hall, R.M. (1995) Gene Cassettes: A New Class of Mobile Element. Microbiology, 141, 3015-3027. http://dx.doi.org/10.1099/13500872-141-12-3015
[16]
Fluit, A.C. and Schmitz, F.J. (2004) Resistance Integrons and Super-Integrons. Clinical Microbiology and Infection, 10, 272-288. http://dx.doi.org/10.1111/j.1198-743X.2004.00858.x
[17]
Lister, P.D., Wolter, D.J. and Hanson, N.D. (2009) Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clinical Microbiology Reviews, 22, 582-610. http://dx.doi.org/10.1128/cmr.00040-09
[18]
Clinical and Laboratory Standards Institute (2006) 15. Performance Standards for Antimicrobial Testing. 16th Informational Supplement. M100-S16, CLSI, Wayne.
[19]
Deng, Y., Bao, X., Ji, L., Chen, L., Liu, J., Miao, J., et al. (2015) Resistance Integrons: Class 1, 2 and 3 Integrons. Annals of Clinical Microbiology and Antimicrobials, 14, 45. http://dx.doi.org/10.1186/s12941-015-0100-6
[20]
Stalder, T., Barraud, O., Casellas, M., Dagot, C. and Ploy, M.-C. (2012) Integron Involvement in Environmental Spread of Antibiotic Resistance. Frontiers in Microbiology, 3, 1-14. http://dx.doi.org/10.3389/fmicb.2012.00119
[21]
Rajabnia, R., Asgharpour, F., Shahandashti, E.F., Khalilian, M., Norkhomami, S., Shafii, M., et al. (2013) Class 1 Integron in Pseudomonas aeruginosa Isolates from Different Places and Devices of ICU in Babol, Iran. Jundishapur Journal of Microbiology, 6, 138-143. http://dx.doi.org/10.5812/jjm.4850
[22]
Papadovasilaki, M., Oberthür, D., Gessmann, R., Sarrou, I., Betzel, C., Scoulica, E., et al. (2015) Biophysical and Enzymatic Properties of Aminoglycoside Adenylyltransferase AadA6 from Pseudomonas aeruginosa. Biochemistry and Biophysics Reports, 4, 152-157. http://dx.doi.org/10.1016/j.bbrep.2015.09.011
[23]
Kumarasamy, K.K., Toleman, M.A., Walsh, T.R., Bagaria, J., Butt, F., Balakrishnan, R., et al. (2010) Emergence of a New Antibiotic Resistance Mechanism in India, Pakistan, and the UK: A Molecular, Biological, and Epidemiological Study. The Lancet Infectious Diseases, 10, 597-602. http://dx.doi.org/10.1016/S1473-3099(10)70143-2
[24]
Stokes, H.W. and Hall, R.M. (1989) A Novel Family of Potentially Mobile DNA Elements Encoding Site-Specific Gene-Integration Functions: Integrons. Molecular Microbi-ology, 3, 1669-1683. http://dx.doi.org/10.1111/j.1365-2958.1989.tb00153.x
Martinez-Freijo, P., Fluit, A.C., Schmitz, F.J., Grek, V.S.C., Verhoef, J. and Jones, M.E. (1998) Class I Integrons in Gram-Negative Isolates from Different European Hospitals and Association with Decreased Susceptibility to Multiple Antibiotic Compounds. Journal of Antimicrobial Chemotherapy, 42, 689-696. http://dx.doi.org/10.1093/jac/42.6.689
[27]
Mathai, E., Grape, M. and Kronvall, G. (2004) Integrons and Multidrug Resistance among Escherichia coli Causing Community Acquired Urinary Tract Infection in Southern India. Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 112, 159-164. http://dx.doi.org/10.1111/j.1600-0463.2004.apm1120301.x
[28]
Liakopoulos, A., Mavroidi, A., Katsifas, E.A., Theodosiou, A., Karagouni, A.D., Miriagou, V., et al. (2013) Carbapenemase-Producing Pseudomonas aeruginosa from Central Greece: Molecular Epidemiology and Genetic Analysis of Class I Integrons. BMC Infectious Diseases, 13, 505. http://dx.doi.org/10.1186/1471-2334-13-505
[29]
Bert, F., Branger, C. and Lambert-Zechovsky, N. (2002) Identification of PSE and OXA β-Lactamase Genes in Pseudomonas aeruginosa Using PCR-Restriction Fragment Length Polymorphism. Journal of Antimicrobial Chemotherapy, 50, 11-18. http://dx.doi.org/10.1093/jac/dkf069
[30]
Riccio, M.L., Docquier, J.D., Dell’Amico, E., Luzzaro, F., Amicosante, G. and Rossolini, G.M. (2003) Novel 3-N-aminoglycoside Acetyltransferase Gene, aac(3)-Ic, from a Pseudomonas aeruginosa Integron. Antimicrobial Agents and Chemotherapy, 47, 1746-1748. http://dx.doi.org/10.1128/AAC.47.5.1746-1748.2003
[31]
Miller, G.H., Sabatelli, F.J., Hare, R.S., Glupczynski, Y., Mackey, P., Shlaes, D., Shimizu, K. and Shaw, K.J. (1997) The Most Frequent Aminoglycoside Resistance Mechanisms—Changes with Time and Geographic Area: A Reflection of Aminoglycoside Usage Patterns. Clinical Infectious Diseases, 24, 46-62. http://dx.doi.org/10.1093/clinids/24.Supplement_1.S46
[32]
Cameron, F.H., Groot Obbink, D.J., Ackerman, V.P. and Hall, R.M. (1986) Nucleotide Sequence of the AAD(2’) Aminoglycoside Adenylyltransferase Determinant aadB. Evolutionary Relationship of This Region with Those Surrounding aadA in R538-1 and Dhfrll in R388. Nucleic Acids Research, 14, 8625-8635. http://dx.doi.org/10.1093/nar/14.21.8625
